Related Experiment Video
Updated: Sep 6, 2025
09:55
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
538
[PET Research in Clinical Oncology]
Takuya Mitsumoto1, Masaru Takabatake2, Kazumasa Inoue2
1Department of Radioisotope Research Center, Teikyo University.
Summary
Positron emission tomography (PET) imaging aids cancer diagnosis and treatment evaluation. This study addresses quantitative accuracy issues in PET scans, exploring methods to improve measurement reliability for better clinical oncology applications.
Area of Science:
- Nuclear Medicine
- Oncology
- Medical Imaging
Background:
- Positron emission tomography (PET) is crucial in clinical oncology for cancer diagnosis, staging, and therapy evaluation.
- 18F-FDG PET/CT offers valuable functional cell information but faces challenges with quantitative accuracy.
- Image reconstruction parameters and patient movement (respiratory, body) can cause fluctuations in quantitative PET values.
Purpose of the Study:
- To review existing PET research in clinical oncology.
- To present novel research aimed at enhancing the quantitativeness of PET imaging.
- To improve the reliability of quantitative PET data for clinical decision-making.
Main Methods:
- Literature review of PET research in clinical oncology.
- Introduction of proprietary research methods focused on improving PET quantitativeness.
- Analysis of factors affecting quantitative accuracy in PET scans.
Main Results:
- Summary of current PET applications and limitations in oncology.
- Demonstration of research approaches to mitigate quantitative fluctuations.
- Highlighting advancements in achieving more precise PET measurements.
Conclusions:
- PET imaging is a powerful tool in oncology, but quantitative accuracy remains a key area for development.
- The presented research offers potential solutions to improve the reliability of PET quantitative values.
- Enhanced quantitativeness in PET will lead to more accurate cancer staging and therapy evaluation.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.4K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.9K
Related Concept Videos
01:16Clinical Trials
7.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.3K
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:28Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
02:43Mouse Models of Cancer Study
5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:21Cancer Survival Analysis
442
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
442